Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Recher

Showing results (391-400 of 488) with videos related to

Pageof 49
Sort By:
Oncotarget|February 5, 2011
Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndromeEmmanuel Raffoux, Audrey Cras, Christian Recher, et al.
Nature Medicine|November 6, 2007
Extralymphatic virus sanctuaries as a consequence of potent T-cell activationMike Recher, Karl S Lang, Alexander Navarini, et al.
British Journal of Haematology|June 19, 2013
Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-HématologiqueMichael Darmon, François Vincent, Laurent Camous, et al.
Blood|July 10, 2014
Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML IntergroupMarie-Anne Hospital, Thomas Prebet, Sarah Bertoli, et al.
Haematologica|February 26, 2015
Dasatinib in high-risk core binding factor acute myeloid leukemia in first complete remission: a French Acute Myeloid Leukemia Intergroup trialNicolas Boissel, Aline Renneville, Thibaut Leguay, et al.
Blood|May 31, 2011
Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalitiesAurore Perrot, Isabelle Luquet, Arnaud Pigneux, et al.
Leukemia|August 22, 2014
Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patientsR Rahmé, X Thomas, C Recher, et al.
Leukemia|January 17, 2013
A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapseS Park, N Chapuis, F Saint Marcoux, et al.
Blood Cancer Journal|May 31, 2022
Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenibAlexander E Perl, Naoko Hosono, Pau Montesinos, et al.
European Journal of Haematology|January 26, 2017
Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemiaXavier Cahu, Martin Carré, Christian Recher, et al.
Pageof 49

Showing results (391-400 of 488) with videos related to

Sort By:
Pageof 49
Oncotarget|February 5, 2011
Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndromeEmmanuel Raffoux, Audrey Cras, Christian Recher, et al.
Nature Medicine|November 6, 2007
Extralymphatic virus sanctuaries as a consequence of potent T-cell activationMike Recher, Karl S Lang, Alexander Navarini, et al.
British Journal of Haematology|June 19, 2013
Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-HématologiqueMichael Darmon, François Vincent, Laurent Camous, et al.
Blood|July 10, 2014
Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML IntergroupMarie-Anne Hospital, Thomas Prebet, Sarah Bertoli, et al.
Haematologica|February 26, 2015
Dasatinib in high-risk core binding factor acute myeloid leukemia in first complete remission: a French Acute Myeloid Leukemia Intergroup trialNicolas Boissel, Aline Renneville, Thibaut Leguay, et al.
Blood|May 31, 2011
Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalitiesAurore Perrot, Isabelle Luquet, Arnaud Pigneux, et al.
Leukemia|August 22, 2014
Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patientsR Rahmé, X Thomas, C Recher, et al.
Leukemia|January 17, 2013
A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapseS Park, N Chapuis, F Saint Marcoux, et al.
Blood Cancer Journal|May 31, 2022
Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenibAlexander E Perl, Naoko Hosono, Pau Montesinos, et al.
European Journal of Haematology|January 26, 2017
Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemiaXavier Cahu, Martin Carré, Christian Recher, et al.
Pageof 49